Therapeutic potential of 1,3,4-oxadiazoles as potential lead compounds for the treatment of Alzheimer's diseaseSaira Naseem, Zahid Shafiq, Muhammad Nawaz Tahir et al.|RSC Advances|2023Cited by 23
2‐Oxoquinoline‐based‐thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitorsRabia Basri, Zahid Shafiq, Aqeel Imran et al.|Archiv der Pharmazie|2023Cited by 3
CCDC 2251452: Experimental Crystal Structure DeterminationSaira Naseem, Zahid Shafiq, Aqeel Imran et al.|The Cambridge Structural Database|2023Cited by 0